| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO, Gen Counsel And Secretary
1 company
Guse Kyle is a CFO, Gen Counsel And Secretary at ATOSSA THERAPEUTICS, INC.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $55K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2017 | ATOS Atossa Therapeutics, Inc. | CFO, Gen Counsel And Secretary | Buy | 10,000 | $0.34 | $3,369.30 | +116.3% |